Accueil > PageWebPerso

GARY-BOBO Magali

par florent_r0s1 - publié le , mis à jour le

Publications :

76. Longevial JF,‡ Yamaji A,‡ Aggad D,‡ Kim G,‡ Xi Chia W, Nishimura T, Miyake Y, Clément S, Oh J, Daurat M, Nguyen C, Kim D,* Gary-Bobo M,* Richeter S*and Shinokubo H*. Diazachlorin and diazabacteriochlorin for one- and two-photon photodynamic therapy. Chem Comm. 2018, DOI : 10.1039/c8cc07489e.

75. Rahmani S, Akrout A, Budimir J, Aggad D, Daurat M, Godefroy A, Nguyen C, Largot H, Gary-Bobo M*, Raehm L, Durand JO, Charnay C*. Hollow Organosilica Nanoparticles for Drug Delivery. ChemistrySelect. 2018, 3, 10439-42.

74. Rascol E, Pisani C, Dorandeu C, Nyalosaso J, Charnay C, Daurat M, Da Silva A, Devoisselle JM, Gaillard JC, Armengaud J, Prat O, Maynadier M, Gary-Bobo M, Garcia M, Chopineau J, Guari Y. Biosafety of mesoporous silica nanoparticles. Biomimetics. 2018, 3(3), 22 DOI : 10.3390/biomimetics3030022.

73. Bouillon C, Poncet F, Bessin Y, Gary-Bobo M, Garcia M, Dumy P, Barboiu M, Bettache N,* and Sébastien Ulrich*. Biomolecular Dynamic Covalent Polymers for DNA complexation and siRNA delivery. J Mater Chem B. 2018, 6, 7239-46.

72. Simon M, Ali LMA, El Cheikh K, Aguesseau J, Gary-Bobo M, Garcia M, Morère A and Maillard LT. Can heterocyclic γ-peptides may provide polyfunctional platforms for synthetic glycocluster construction ? Chem Eur J. 2018, 24, 11426-32.

71. Tarhouni M, Durand D, Önal E, Aggad D, İşci U, Ekineker G, Brégier F, Jamoussi B, Sol V, Gary-Bobo M, Dumoulin F. Triphenylphosphonium-substituted phthalocyanine : design, synthetic strategy, photoproperties and photodynamic activity. JPP. 2018, 22, 552-61.

70. Théron C, Birault A, Bernhardt M, Ali LMA, Nguyen C, Gary-bobo M, Bartlett JR, Wong Chi Man M, Carcel C. New precursors for the preparation of pH-sensitive, targeting and loaded non porous bridged silsesquioxane nanoparticles. J Sol-Gel Sci Technol. 2018, doi.org/10.1007/s10971-018-4676-0.
(IF : 1.745)

69. Ali LMA, Mathlouthi E, Kajdan M, Daurat M, Long J, Sidi-Boulenouar R, Cardoso M, Goze-Bac C, Amdouni N, Guari Y, Gary-Bobo M*. Multifunctional manganese-doped Prussian blue nanoparticles for two-photon Photothermal Therapy and Magnetic Resonance Imaging.
Photodiag and Photodyn Ther. 2018, 22, 65-9.

68. Mauriello Jimenez C, Aggad D, Croissant JG, Tresfield K, Laurencin D, Berthomieu D, Cubedo N, Rossel M, Alsaiari S, Anjum DH, Sougrat R, Roldan-Gutierrez MA, Richeter S, Oliviero E, Raehm L, Charnay C, Cattoën X, Clément S, Wong Chi Man M, Maynadier M, Chaleix V, Sol V, Garcia M, Gary-Bobo M, Khashab NM, Bettache N,* and Durand JO. Porous Porphyrin-Based Organosilica Nanoparticles for NIR Two-Photon Photodynamic Therapy and Gene Delivery in Zebrafish. Adv Funct Mat. 2018, DOI : 10.1002/adfm.201800235. Cover done !

67. Chaix A, Rajoua K, Stonajovic V, Khaled El Cheikh K, Bouffard E, Brocéro A, Garcia M, Maynadier M, Morère A, Gary-Bobo M, Favier F, Durand JO and Cunin F*. Two-photon fluorescence imaging and therapy of cancer cells with anisotropic gold nanoparticles supported porous silicon nanostructures. ChemNanoMat. 2018, DOI : 10.1002/cnma.201700368. Cover done !
66. Basile I, da Silva A, El Cheikh K, Godefroy A, Daurat M, Harmois A, Perez M, Caillaud C, Charbonné H-V, Gary-Bobo M, Morère A, Garcia M, Maynadier M., Mannose 6-phosphate analogue grafting on acid α-glucosidase induces efficient therapy in adult Pompe mice. J Control Release 2018, 269, 15-23. Editorial and cover done !

65. Aggad D, Mauriello Jimenez C, Dib S, Croissant JG, Lichon L, Laurencin D, Richeter S, Maynadier M, Alsaiari SK, Boufatit M, Raehm L, Garcia M, Khashab NM, Gary-Bobo M* & Durand JO. Gemcitabine Delivery and Photodynamic Therapy in cancer cells via Porphyrin-Ethylene-Based Periodic Mesoporous Organosilica Nanoparticles. ChemNanoMat. 2018, 4, 46-51.

64. Mauriello Jimenez C, Henry M, Aggad D, Raehm L, Cattoën X, Wong Chi Man M, Charnay C, Alpugan S, Ahsen V, Kutlu Tarakci D, Maillard P, Maynadier M, Garcia M, Dumoulin F, Gary-Bobo M*, Coll JL, Josserand V & Durand JO. Porphyrin or phthalocyanine-bridged silsesquioxane theranostic nanoparticles for two-photon imaging, photodynamic therapy or photoacoustic imaging. Nanoscale 2017, 9, 16622-6.

63. Rahmani S, Chaix A, Aggad D, Hoang P, Moosa B, Garcia M, Gary-Bobo M, Charnay C, AlMalik A, Durand JO, Khashab NM. Degradable gold core mesoporous organosilica shell nanoparticles for two-photon imaging and gemcitabine monophosphate delivery. Molecular Systems Design & Engineering 2017, 2, 380-3.

62. Bouchal R, Daurat M, Gary-Bobo M, Da Silva A, Lesaffre L, Aggad D, Godefroy A, Dieudonné P, Charnay C, Durand JO, Hesemann P. Biocompatible Periodic Mesoporous Ionosilica Nanoparticles with Ammonium Walls : Application to Drug Delivery. ACS Appl Mater Interfaces 2017, 9, 32018-25.

61. Liu W, Chaix A, Gary-Bobo M, Angeletti B, Masion A, Da Silva A, Daurat M, Lichon L, Garcia M, Morère A, El Cheikh K, Durand JO, Cunin F and Auffan M. Development of stealth and biocompatible Si-based nanoparticles devoted to biomedical applications. Nanomaterials 2017, 7, 288.

60. Longevial JF, El Cheikh K, Aggad D, Lebrun A, Van der Lee A, Tielens F, Clément S, Morère A, Garcia M, Gary-Bobo M*, Richeter S. Porphyrins Conjugated with Peripheral Thiolato Gold(I) Complexes for Enhanced Photodynamic Therapy. Chem Eur J. 2017, 23, 14017-26. Hot Paper

59. Rascol E, Daurat M, Da Silva A, Maynadier M, Dorandeu C, Charnay C, Garcia M, Lai-Kee-Him J, Bron P, Auffan M, Liu W, Angeletti B, Devoisselle JM, Guari Y, Gary-Bobo M*, Chopineau J. Biological Fate of Fe3O4 Core-Shell Mesoporous Silica Nanoparticles Depending on Particle Surface Chemistry. Nanomaterials 2017, 7, 162.

58. Rahmani S, Durand JO, Charnay C, Lichon L, Ferid M, Garcia M, Gary-Bobo M*. Synthesis of mesoporous silica nanoparticles and nanorods : Application to doxorubicin delivery. Solid State Sciences 2017, 68, 25-31.

57. El Cheikh K, Basile I, Da Silva A, Bernon C, Cérutti P, Salgues F, Perez M, Maynadier M, Gary-Bobo M, Caillaud C, Cérutti M, Garcia M, Morère A. Potent Mannose 6-Phosphate Analogues Designed for the Functionalization of Lysosomal Enzymes : A Way to Improve the Pompe Disease Treatment. Angew Chem Int Ed Engl. 2016, 55, 14774-7.

56. Stojanovic V, Cunin F, Durand JO, Garcia M and Gary-Bobo M*. Potential of Porous Silicon Nanoparticles (pSiNPs) as an Emerging Platform for Cancer Theranostic. J Mater Chem B. 2016, 4, 7050-9.

55. Mauriello Jimenez C, Knezevic NZ, Galàn Rubio Y, Szunerits S, Boukherroub R, Teodorescu F, Croissant JG, Hocine O, Seric M, Raehm L, Stojanovic V, Aggad D, Maynadier M, Garcia M, Gary-Bobo M* and Durand JO*. Nanodiamond–PMO for two-photon PDT and drug delivery. J Mater Chem B. 2016, 4, 5803-8.

54. Croissant J, Picard S, Aggad D, Klausen M, Mauriello Jimenez C, Maynadier M, Mongin O, Clermont G, Genin E, Cattoën X, Wong Chi Man M, Raehm L, Garcia M, Gary-Bobo M*, Blanchard-Desce M* and Durand JO*. Fluorescent Periodic Mesoporous Organosilica Nanoparticles Dual-Functionalized via Click Chemistry for Two-Photon Photodynamic Therapy in Cells. J Mater Chem B. 2016, 4, 5567-74.

53. Nyalosaso JL, Rascol E, Pisani C, Dorandeu C, Dumail X, Maynadier M, Gary-Bobo M, Lai Kee Him J, Bron P, Garcia M, Devoisselle JM, Prat O, Guari Y, Charnay C and Chopineau J. Synthesis, decoration, and cellular effects of magnetic mesoporous silica nanoparticles. RSC Advances. 2016, 6, 57275-83.

52. Noureddine A, Gary-Bobo M, Lichon L, Garcia M, Zink JI, Wong Chi Man M, Cattoën X. Bis-clickable mesoporous silica nanoparticles : straightforward preparation of light-actuated nanomachines for controlled drug delivery with active targeting. Chem Eur J. 2016, 22, 9624-30.

51. Chaix A, El Cheikh K, Bouffard E, Maynadier M, Aggad D, Stojanovic V, Knezevic N, Garcia M, Maillard P, Morère A, Gary-Bobo M, Raehm L, Richeter S, Cunin F. Mesoporous silicon nanoparticles for targeted two-photon theranostic of prostate cancer. J Mater Chem B. 2016, 4, 3639-42.

50. Mauriello Jimenez C, Galàn Rubio Y, Saunier V, Warther D, Stojanovic V, Raehm L, Frochot C, Arnoux P, Garcia M, Morère A, Bettache N, Maynadier M, Maillard P, Gary-Bobo M and Durand JO. 20 nm sized mesoporous silica nanoparticles with porphyrin photosensitizers for in-vitro photodynamic therapy. J Sol-Gel Sci Technol. 2016, 79, 447.

49. Agnaniet H, Mbot E J, Keita O, Fehrentz J A, Ankli A, Gallud A, Garcia M, Gary-Bobo M, Lebibi J, Cresteil T, Menut C. Antidiabetic potential of two medicinal plants used in Gabonese folk medicine. BMC Complement Altern Med 2016, 16, 71.

48. Knezevic NZ, Stojanovic V, Chaix A, Bouffard E, El Cheikh K, Morère A, Maynadier M, Lemercier G, Garcia M, Gary-Bobo M, Durand JO and Cunin F. Ruthenium(II) complex-photosensitized multifunctionalized porous silicon nanoparticles for two-photon near-infrared light responsive imaging and photodynamic cancer therapy. J Mater Chem B 2016, 4, 1337-42.

47. Croissant JG, Qi C, Maynadier M, Cattoën X, Wong Chi Man M, Raehm L, Mongin O*, Blanchard-Desce M, Garcia M, Gary-Bobo M and Durand JO. Multifonctional gold-mesoporous silica nanocomposites for enhanced two-photon imaging and therapy of cancer cells. Front Mol Biosci. 2016, 3, 1.

46. Gallud A, Warther D, Maynadier M, Sefta M, Poyer F, Thomas C, Rouxel C, Mongin O, Blanchard-Desce M, Morère A, Raehm L, Maillard P, Durand JO, Garcia M, Gary-Bobo M*. Identification of MRC2 and CD209 receptors as targets for photodynamic therapy of retinoblastoma using mesoporous silica nanoparticles. RSC Advances. 2015, 5, 75167-72.

45. Bartolami E, Bessin Y, Bettache N, Gary-Bobo M, Garcia M, Dumy P, Ulrich S. Multivalent DNA recognition by self-assembled clusters : deciphering structural effects by fragments screening and evaluation as siRNA vectors. Org Biomol Chem. 2015, 13, 9427-38.

44. Bouffard E, El Cheikh K, Gallud A, Da Silva A, Maynadier M, Basile I, Gary-Bobo M, Morere A, Garcia M. Why anticancer nanomedicine needs sugars ? Curr Med Chem. 2015, 22, 3014-24.

43. Théron C, Gallud A, Giret S, Maynadier M, Grégoire D, Puche P, Jacquet E, Pop G, Sgarbura O, Bellet V, Hibner U, Zink JI,* Garcia M, Wong Chi Man M, Carcel C* and Gary-Bobo M*. pH-operated Hybrid Silica Nanoparticles with Multiple H-bond Stoppers for Colon Cancer Therapy. RSC Advances. 2015, 5 : 64932-6.

42. Croissant JG, Qi C, Mongin O*, Hugues V, Blanchard-Desce M, Raehm L, Cattoën X, Wong Chi Man M, Maynadier M, Gary-Bobo M, Garcia M, Zink JI* and Durand JO*. Disulfide-gated mesoporous silica nanoparticles designed for two-photon-triggered drug release and imaging. J Mater Chem B. 2015, 3 : 6456-61.

41. Croissant JG, Mauriello-Jimenez C, Maynadier M, Cattoën X, Wong Chi Man M, Raehm L, Mongin O, Blanchard-Desce M, Garcia M, Gary-Bobo M*, Maillard P and Durand JO*. Synthesis of disulfide-based biodegradable bridged silsesquioxane nanoparticles for two photon imaging and therapy of cancer cells. Chem. Comm. 2015, 51:12324-7.

40. Maynadier M*, Basile I, Gallud A, Gary-Bobo M and Garcia M*. Combination treatment with proteasome inhibitors and anti-estrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer. Oncol Rep. 2015, 36 : 1127-34.

39. Noureddine A, Lichon L, Maynadier M, Garcia M, Gary-Bobo M, Zink JI, Wong Chi Man M. Controlled Multiple Functionalization of Mesoporous Silica Nanoparticles : Homogeneous Implementation of pairs of Functionalities Communicating through Energy or Proton Transfers. Nanoscale. 2015, 7 : 11444-52.

38. Perrier M, Gallud A, Ayadi A, Kennouche S, Porredon C, Gary-Bobo M*, Larionova J*, Goze-Bac C, Zanca M, Garcia M, Basile I, Long J, de Lapuente J, Borras M, Guari Y. Investigation of cyano-bridged coordination nanoparticles Gd3+/[Fe(CN)6]3-/d-mannitol as T1-weighted MRI contrast agents. Nanoscale. 2015, 7 : 11899-903. Cover done !

37. Croissant J, Mongin O, Hugues V, Blanchard-Desce M, Cattoën X, Wong Chi Man M, Charnay C, Maynadier M, Garcia M, Gary-Bobo M, Raehm L, Durand JO. Influence of the Synthetic Method on the Properties of Mesoporous Silica Nanoparticles Designed for Two-Photon Excitation. J Mater Chem B. 2015, 3 : 5182-8.

36. Mauriello-Jimenez C, Croissant J, Maynadier M, Cattoën X, Wong Chi Man M, Vergnaud J, Chaleix V, Sol V, Garcia M, Gary-Bobo M, Raehm L, Durand JO. Porphyrin-Functionalized Mesoporous Organosilica Nanoparticles for Two-Photon Imaging of Cancer Cells and Drug Delivery. J Mater Chem B. 2015, 3 : 3681-4.

35. Vaillant O, El Cheikh K, Warther D, Brevet D, Maynadier M, Bouffard E, Salgues F, Jeanjean A, Puche P, Mazerolles M, Maillard P, Mongin O, Blanchard-Desce M, Raehm L, Rébillard X, Durand JO,* Gary-Bobo M, * Morère A* and Garcia M. Mannose-6-phosphate receptor as a new target for theranostic of prostate cancer. Angew Chem Int Ed Engl. 2015, 54 : 5952-6.

34. Croissant J, Maynadier M, Mongin O, Hugues V, Blanchard-Desce M, Chaix A, Cattoën X, Wong Chi Man M, Gallud A, Gary-Bobo M, Garcia M, Raehm L, Durand JO. Enhanced Two-Photon Fluorescence Imaging and Therapy of Cancer Cells via Gold@Bridged Silsesquioxane Nanoparticles. Small, 2015, 11 : 295-9.

33. Secret E, Maynadier M, Gallud A, Chaix A, Bouffard E, Gary-Bobo M, Marcotte N, Mongin O, El Cheikh K, Hugues V, Auffan M, Frochot C, Morère A, Maillard P, Blanchard-Desce M, Sailor MJ, Garcia M, Durand JO, Cunin F. Two-Photon Excitation of Porphyrin-Functionalized Porous Silicon Nanoparticles for Photodynamic Therapy. Adv Mater. 2014, 26 : 7643-8.

32. Croissant J, Salles D, Maynadier M, Mongin O, Hugues V, Blanchard-Desce M, Cattoën X, Wong Chi Man M, Gallud A, Garcia M, Gary-Bobo M, Raehm L, Durand JO. Mixed Periodic Mesoporous Organosilica Nanoparticles and Core-Shell Systems, Application to in Vitro Two-Photon Imaging, Therapy and Drug Delivery. Chem Mater 2014, 26 : 7214-20.

31. Warther D, Mauriello-Jimenez C, Raehm L, Gérardin C, Durand JO, Morère A, El Cheikh K, Gallud A, Gary-Bobo M, Maynadier M and Garcia M. Small sized mesoporous silica nanoparticles functionalized with mannose for retinoblastoma cell imaging. RSC Advances. 2014, 4 : 37171-9.

30. Théron C I, Gallud A, Carcel C*, Gary-Bobo M*, Maynadier M, Garcia M, Lu J, Tamanoi F, Zink J, Wong Chi Man M*. Hybrid mesoporous silica nanoparticles with pH-operated and complementary H-bonding stoppers as autonomous drug delivery system. Chem. Eur. J. 2014, 20 : 9372-80.

29. Bakarnga-Via I, Hzounda JB, Fokou PV, Tchokouaha LR, Gary-Bobo M, Gallud A, Garcia M, Walbadet L, Secka Y, Dongmo PM, Boyom FF, Menut C. Composition and cytotoxic activity of essential oils from Xylopia aethiopica (Dunal) A. Rich, Xylopia parviflora (A. Rich) Benth.) and Monodora myristica (Gaertn) growing in Chad and Cameroon. BMC Complement Altern Med. 2014, 14:125.
(IF : 2.109)

28. Croissant J, Chaix A, Mongin O, Wang M, Clément S, Raehm L, Durand JO,* Hugues V, Blanchard-Desce M, Maynadier M, Gallud A, Gary-Bobo M,* Garcia M, Lu J, Tamanoi F, Ferris DP, Tarn D, Zink JI *. Two-Photon-Triggered Drug Delivery via Fluorescent Nanovalves. Small, 2014, 10:1752-5.

27. Noudogbessi JP, Gary-Bobo M, Adomou A, Adjalian E, Alitonou GA, Avlessi F, Garcia M, Sohounhloue DCK and Menut C*. Comparative Chemical Study and Cytotoxic Activity of Uvariodendron angustifolium Essential Oils from Benin. Nat Prod Commun. 2014, 9 : 261-4.

26. Croissant J, Maynadier M, Gallud A, Peindy N’Dongo H, Nyalosaso JL, Derrien G, Charnay C, Durand JO,* Raehm L, Serein Spirau F, Cheminet N, Jarrosson T, Mongin O, Blanchard-Desce M, Gary-Bobo M,* Garcia M, Lu J, Tamanoi F, Tarn D, Guardado-Alvarez TM, and Zink JI *. Two-Photon-Triggered Drug Delivery in Cancer Cells Using Nanoimpellers. Angew Chem Int Ed Engl. 2013, 52 : 13813-7.

25. Maynadier M, Vezenkov L L, Amblard M, Martin V, Gandreuil C, Vaillant O, Gary-Bobo M, Basile I, Hernandez JF, Garcia M, Martinez J. Dipeptide mimic oligomer transporter mediates intracellular delivery of cathepsinD inhibitors : A potential target for cancer therapy. J Control Release. 2013, 171 : 251-7.

24. Gallud A, Da Silva A, Maynadier M, Basile I, Fontanel S, Lemaire C, Maillard P, Blanchard-Desce M, Mongin O, Morère A, Durand JO, Raehm L, Garcia M and Gary-Bobo M*. Functionalized nanoparticles for drug delivery, one- and two-photon photodynamic therapy as a promising treatment of retinoblastoma. JCEO. 2013, 4:288-91.

23. Giret S, Théron C, Gallud A, Maynadier M, Gary-Bobo M, Garcia M, Wong Chi Man M, Carcel C. A Designed 5-FU Based-bridged Silsesquioxane as Autonomous Acid-triggered Drug Delivery System. Chem. Eur. J. 2013, 19:12806-14.

22. Secret E, Maynadier M, Gallud A, Gary-Bobo M, Chaix A, Maillard P, Sailor MJ, Garcia M, Durand JO, Cunin F. Anionic porphyrin-grafted porous silicon nanoparticles for photodynamic therapy. Chem Commun (Camb). 2013, 49 : 4202-4.

21. Perrier M, Gary-Bobo M, Lartigue L, Brevet D, Morère A, Garcia M, Maillard P, Raehm L, Guari Y, Larionova J, Durand JO, Mongin O, Blanchard-Desce M. Mannose-functionalized porous silica coated magnetic nanoparticles for two-photon imaging or PDT of cancer cells. J Nanoparticle Research. 2013, 15 : 1602.

20. Gary-Bobo M, Vaillant O, Maynadier M, Basile I, Gallud A, El Cheikh K, Bouffard E, Morère A, Rébillard X, Puche P, Nirdé P, Garcia M. Targeting Multiplicity : the Key Factor for Anti-cancer Nanoparticles. Curr Med Chem. 2013, 20:1946-55.

19. Maynadier M, Shi J, Vaillant O, Gary-Bobo M, Basile I, Gleizes M, Cathiard AM, Lee Tin Wah J, Sheikh MS, Garcia M. Roles of estrogen receptor and p21WAF1 in bortezomib-induced growth inhibition in human breast cancer cells. Mol Cancer Res. 2012 ; 10 : 1473-81.

18. Maynadier M, Chambon M, Basile I, Gleizes M, Nirde P, Gary-Bobo M, Garcia M. Estrogens promote cell-cell adhesion of normal and malignant mammary cells through increased desmosome formation. Mol Cell Endocrinol. 2012 ; 364:126-33.

17. Laurent-Matha V, Huesgen PF, Masson O, Derocq D, Prébois C, Gary-Bobo M, Lecaille F, Rebière B, Meurice G, Oréar C, Hollingsworth RE, Abrahamson M, Lalmanach G, Overall CM, Liaudet-Coopman E. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. FASEB J. 2012 ; 26 : 5172-81.

16. Gary-Bobo M, Mir Y, Rouxel C, Brevet D, Hocine O, Maynadier M, Gallud A, Da Silva A, Mongin O, Blanchard-Desce M, Richeter S, Loock B, Maillard P, Morère A, Garcia M, Raehm L, Durand JO. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma : Drug delivery, one and two-photon photodynamic therapy. Int J Pharm. 2012 ; 432 : 99-104.

15. Gary-Bobo M, Brevet D, Benkirane-Jessel N, Raehm L, Maillard P, Garcia M and Durand JO. Hyaluronic Acid-functionalized Mesoporous Silica Nanoparticles for Efficient Photodynamic Therapy of Cancer Cells. Photodiagnosis Photodyn Ther. 2012 ; 9 : 256-60.

14. Gary-Bobo M, Hocine O, Brevet D, Maynadier M, Raehm L, Richeter S, Charasson V, Loock B, Morère A, Maillard P, Garcia M and Durand JO. Cancer Therapy Improvement with Mesoporous Silica Nanoparticles Combining Targeting, Drug Delivery and PDT. Int J Pharm. 2012, 423 : 509-15.

13. Gary-Bobo M, Mir Y, Rouxel C, Brevet D, Basile I, Maynadier M, Vaillant O, Mongin O, Blanchard-Desce M*, Morère A, Garcia M*, Durand JO*, Raehm L. Mannose-Functionalized Mesoporous Silica Nanoparticles for Efficient Two-Photon Photodynamic Therapy of Solid Tumours. Angew Chem Int Ed Engl. 2011, 50 : 11425-9.

12. Chelebaeva E, Larionova J, Guari Y, Ferreira RAS, Carlos LD, Trifonov AA, Kalaivani T, Lascialfari A, Guérin C, Molvinger K, Datas L, Maynadier M, Gary-Bobo M and Garcia M. Nanoscale Coordination Polymers Exhibiting Luminescence Properties and NMR Relaxivity. Nanoscale. 2011, 3 : 1200-10.

11. Hocine O*, Gary-Bobo M*, Brevet D, Maynadier M, Fontanel S, Raehm L, Richeter S, Loock B, Couleaud P, Frochot C, Charnay C, Derrien G, Smaïhi M, Sahmoune A, Morère A, Maillard P, Garcia M, Durand JO. Silicalites and Mesoporous Silica Nanoparticles for photodynamic therapy. Int J Pharm. 2010, 402 : 221-30. * : contribute equally to this work.

10. Nirdé P, Derocq D, Maynadier M, Chambon M, Gary-Bobo M and Garcia M. Heat shock cognate 70 protein secretion as a new growth arrest signal for cancer cells. Oncogene. 2010, 9 :117-27.

9. Brevet D*, Gary-Bobo M*, Raehm L, Richeter S, Hocine O, Amro K, Loock B, Maillard P, Couleaud P, Frochot C, Morère A, Garcia M and Durand JO. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Commun (Camb). 2009, 28:1475-7. * : contribute equally to this work. Hot paper.

8. Maynadier M, Basile I and Gary-Bobo M*. Adiponectin normalization : a clue to the anti-metabolic syndrome action of rimonabant. Drug Discov Today. 2009, 14, 192-7.

7. Jeanjean A*, Gary-Bobo M*, Nirdé P, Leiris S, Garcia M, Morère A. Synthesis of new sulfonate and phosphonate derivatives for cation-independent mannose 6-phosphate receptor targeting. Bioorg Med Chem Lett. 2008, 18 : 6240-3. * : contribute equally to this work.

6. Gary-Bobo M, Nirdé P, Jeanjean A, Morère A, Garcia M. Mannose 6-phosphate receptor targeting and its applications in human diseases. Curr Med Chem. 2007 ; 14 : 2945-53.

5. Gary-Bobo M, Elachouri G, Gallas JF, Janiak P, Marini P, Ravinet-Trillou C, Chabbert M, Cruccioli N, Pfersdorff C, Roque C, Arnone M, Croci T, Soubrié P, Oury-Donat F, Maffrand JP, Scatton B, Lacheretz F, Le Fur G, Herbert JM, Bensaid M. Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology. 2007, 46 : 122-9.

4. Gary-Bobo M, Elachouri G, Scatton B, Le Fur G, Oury-Donat F, Bensaid M. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Mol Pharmacol. 2006, 69 : 471-8.

3. Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrié P. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol. 2003, 63 : 908-14.

2. Lafont V, Loisel S, Liautard J, Dudal S, Sablé-Teychené M, Liautard JP, Favero J. Specific signaling pathways triggered by IL-2 in human V gamma 9V delta 2 T cells : an amalgamation of NK and alpha beta T cell signaling. J Immunol. 2003, 171 : 5225-32.
(IF : 4.539)

1. Lafont V, Liautard J, Sablé-Teychené M, Sainte-Marie Y, Favero J. Isopentenyl pyrophosphate, a mycobacterial non-peptidic antigen, triggers delayed and highly sustained signaling in human gamma delta T lymphocytes without inducing down-modulation of T cell antigen receptor. J Biol Chem. 2001, 276 : 15961-7.

Patents :

7. Durand JO, Mauriello Jimenez C,Raehm L, Richeter S, Gary-Bobo M, Maynadier M, Garcia M. Nanoparticules d’organosilice mésoporeuses périodiques pour la théranostique à deux photons et la délivrance de médicaments anti-cancéreux. Brevet d’invention dépôt CNRS, N° 16 50396, 2016

6. Sourdon A, Mongin O, Blanchard-Desce M, Gary-Bobo M, Garcia M, Maynadier M. Dendrimères photosensibilisateurs biphotoniques, procédé de fabrication et utilisations. Demande Fr. 2015, FR 2015-61898.

5. Garcia M, Vaillant O, Morère A, Gary-Bobo M, Mazerolles C, Rébillard X. Le récepteur mannose 6-phosphate cation indépendant une cible pour le diagnostic et le traitement des cancers de la prostate. Brevet d’invention FR, (23 1 2014), N°1450588 demandeur CNRS.

4. Cunin F, Durand JO, Sailor MJ, Garcia M, Secret M, Gary-Bobo M, Maynadier M. Nanoparticules de silicium poreux fonctionnalisées et leurs utilisations en thérapie photodynamique. Brevet d’invention, N° FR1252703(2012), demandeur CNRS.

3. Blanchard-Desce M, Brevet D, Raehm L, Mongin O, Gary-Bobo M, Garcia M, Morère A, Durand JO. Photosensibilisateurs biphotoniques, nanoparticules les comprenant. Brevet d’invention, N° EP 09 306 238.8 (2009), demandeur CNRS, PCT/EP2010/069035, WO2011/073054.

2. Maillard P, Garcia M, Gary-Bobo M, Morère A., Durand JO, Brevet D, Hocine O, Amro K, Smaihi M, Richeter S, Frochot C, Couleaud P. Dérivés de métalloporphyrines, nanoparticules les comprenant. Brevet d’invention, N° 08/05034 (2008), demandeur CNRS, PCT/Fr 2009/001090, WO 2010/9409003.

1. Garcia M, Morère A, Cérutti M, Gary-Bobo M, Nirdé P, Basile I, El Cheikh K. Neoglycoenzymes pour le traitement des maladies lysosomales. Brevet d’invention, N° EP 09305647, (2009), demandeur INSERM, PCT/EP2010/059507, WO 2011/000958.